Jpmorgan Chase & CO Adaptive Biotechnologies Corp Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 887,833 shares of ADPT stock, worth $4.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

887,833

Previous 902,557 1.63%

Holding current value

$4.16 Million

Previous $3.27 Million 39.12%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$3.37 - $5.12 $49,619 - $75,386	-14,724 Reduced 1.63%	887,833 $4.55 Million
Q2 2024 Aug 12, 2024	BUY	$2.34 - $3.96 $1.61 Million - $2.73 Million	689,050 Added 322.73%	902,557 $3.27 Million
Q1 2024 May 10, 2024	SELL	$2.88 - $4.8 $197,167 - $328,612	-68,461 Reduced 24.28%	213,507 $685,000
Q4 2023 Feb 12, 2024	SELL	$3.46 - $5.33 $69,739 - $107,431	-20,156 Reduced 6.67%	281,968 $1.38 Million
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $45,995 - $76,567	-9,072 Reduced 2.92%	302,124 $1.65 Million
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $1.32 Million - $1.87 Million	-212,552 Reduced 40.58%	311,196 $2.09 Million
Q1 2023 May 18, 2023	BUY	$7.8 - $10.11 $1.09 Million - $1.41 Million	139,339 Added 36.25%	523,748 $4.62 Million
Q1 2023 May 11, 2023	SELL	$7.8 - $10.11 $148,090 - $191,948	-18,986 Reduced 4.71%	384,409 $3.39 Million
Q4 2022 Feb 13, 2023	SELL	$6.26 - $9.34 $881,714 - $1.32 Million	-140,849 Reduced 25.88%	403,395 $3.08 Million
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $107,536 - $209,612	-16,544 Reduced 2.95%	544,244 $3.88 Million
Q2 2022 Aug 11, 2022	BUY	$6.4 - $14.73 $1.48 Million - $3.41 Million	231,673 Added 70.39%	560,788 $4.54 Million
Q1 2022 May 11, 2022	BUY	$10.12 - $28.9 $500,444 - $1.43 Million	49,451 Added 17.68%	329,115 $4.57 Million
Q4 2021 Feb 10, 2022	BUY	$25.17 - $36.85 $2.42 Million - $3.55 Million	96,280 Added 52.5%	279,664 $7.85 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $5.51 Million - $7.31 Million	183,384 New	183,384 $6.23 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Adaptive Biotechnologies Corp Transaction History